DISCLOSED ARE A NOVEL COMPOUND AND A PHARMACEUTICAL PRODUCT, EACH HAVING A REMARKABLE URICOSURIC EFFECT. SPECIFICALLY DISCLOSED ARE: A NOVEL PHENOL DERIVATIVE REPRESENTED BY GENERAL FONNULA (1) THAT IS SHOWN IN FIG. 1； A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF；A HYDRATE OF THE DERIVATIVE OR THE SALT； AND A SOLVATE OF THE DERIVATIVE OR THE SALT. (IN THE FORMULA, R1 AND R2 MAY BE THE SAME OR DIFFERENT AND EACH REPRESENTS A LOWER ALKYL GROUP, A LOWER ALKENYL GROUP, A LOWER ALKYNYL GROUP, A LOWER ALKOXY GROUP, A HALOALKYL GROUP, A HALOALKOXY GROUP, AN ALKYLSULFANYL GROUP, AN ALKYLSULFINYL GROUP, AN ALKYLSULFONYL GROUP, A LOWER ALKYL-SUBSTITUTED CARBARNOYL GROUP , A SATURATED NITROGEN-CONTAINING HETEROCYCLIC N-CARBONYL GROUP, A HALOGEN ATOM, A CYANO GROUP OR A HYDROGEN ATOM； R3 REPRESENTS A LOWER ALKYL GROUP, A HALOALKYL GROUP, A HALOGEN ATOM, A HYDROXY GROUP OR A HYDROGEN ATOM； AND X REPRESENTS A SULFUR ATOM, AN -S (=O)- GROUP OR AN -S(=O)2- GROUP.) FIGURE 1
